News for Ironwood Pharmaceuticals, Inc. - Google Finance

Ironwood Pharmaceuticals to raise $136M in stock offering

Thu, 23 May 2013 22:10:20 GMT

Ironwood Pharmaceuticals to raise $136M in stock offering
Boston Herald - May 23, 2013

Ironwood Pharmaceuticals Inc. will close its public offering of 10.5 million shares of stock worth nearly $136.5 million tomorrow.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) drug Linzess might not be ...

Wed, 22 May 2013 07:49:48 GMT

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) drug Linzess might not be ...
GSPInsider - May 22, 2013

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) closed its day at $13.49. The introductory price for the day was $13.41, during the day the stock jumped to hit its day high of $13.71 and fell to $13.16 during the day, while the average true range of the ...

Ironwood Pharma Prices $136.5 Mln Stock Offering - NASDAQ

NASDAQ Active Stock Watch List: Ironwood Pharmaceuticals, Inc. (NASDAQ ...

Wed, 22 May 2013 14:56:21 GMT

NASDAQ Active Stock Watch List: Ironwood Pharmaceuticals, Inc. (NASDAQ ...
SBWire (press release) - May 22, 2013

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) an entrepreneurial pharmaceutical company that discovers, develops, and commercializes human therapeutic products is currently down (-4.60%) on 4,070,877 traded after Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals Inc. (IRWD) Is Falling After Offering Announcement

Mon, 20 May 2013 20:35:24 GMT

Ironwood Pharmaceuticals Inc. (IRWD) Is Falling After Offering Announcement
RTT News - May 20, 2013

Ironwood Pharmaceuticals Inc. (IRWD: Quote) announced after the bell Monday that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.

IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals ...

Mon, 20 May 2013 20:07:42 GMT

IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals ...
4-traders (press release) - May 20, 2013

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) down by 4.30%, Astex ...

Thu, 23 May 2013 04:20:55 GMT

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) down by 4.30%, Astex ...
NIS - May 23, 2013

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) closed its day at $12.91 after falling 4.30%, hit a high of $13.65 and a low of $12.65, the average true range of the stock is $0.67.

Ironwood Pharma Prices Stock Offering - Analyst Blog

Thu, 23 May 2013 16:32:49 GMT

Ironwood Pharma Prices Stock Offering - Analyst Blog
NASDAQ - May 23, 2013

Ironwood Pharmaceuticals, Inc. ( IRWD ) recently priced a public offering of 10.5 million shares of Class A common stock at $13.00 per share.

IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals to Present ...

Tue, 07 May 2013 20:09:53 GMT

IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals to Present ...
4-traders (press release) - May 7, 2013

Ironwood Pharmaceuticals (NASDAQ: IRWD) is committed to the art and science of making medicines, from discovery through commercialization.

Ironwood Pharmaceuticals Downgraded to Neutral at Cowen Securities (IRWD) - Zolmax

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) and Ariad Pharmaceuticals Inc ...

Fri, 17 May 2013 05:20:38 GMT

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) and Ariad Pharmaceuticals Inc ...
NIS - May 17, 2013

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD): In Thursday's trading session, Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) dropped 3.12%. Its opening price of $15.01 was also the intraday high, which eventually headed down to close at $14.60 per ...

NASDAQ Decliners Watch List: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ...

Tue, 07 May 2013 13:03:58 GMT

NASDAQ Decliners Watch List: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ...
SBWire (press release) - May 7, 2013

New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Exact Sciences Corporation (NASDAQ:EXAS), and Ironwood Pharmaceuticals, Inc.